Tags : CEPI

PharmaShots Weekly Snapshot (Nov 02-06, 2020)

Tuba Khan November 6, 2020

AstraZeneca’s Brilinta (ticagrelor) Receives the US FDA’s Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Published: Nov 6, 2020 | Tags: AstraZeneca, Brilinta, ticagrelor, Receives, US FDA, Approval, Acute, High,Risk, Transient, Ischaemic, Stroke Novo Nordisk to Acquire Emisphere Technologies for $1.8B Published: Nov 6, […]Read More

Regulatory

CEPI to Invest ~$328M in Clover’s COVID-19 Vaccine Candidate

Tuba Khan November 4, 2020

Shots: CEPI’s total investment in Clover’s S-Trimer vaccine candidate will be up to $328 M, including $69.5M previously announced have funded preclinical studies and P-l study, preparations for the global pivotal P-ll/lll efficacy study, and initial manufacturing scale-up activities The expanded collaboration will provide $258.5M for a global pivotal P-ll/lll efficacy clinical trial which is […]Read More

COVID-19

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

Tuba Khan June 30, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Biotech

AstraZeneca Signs an Agreement with Serum Institute to Supply 1B

Tuba Khan June 5, 2020

Shots: Novartis signed an agreement with CEPI and Gavi, worth $750M to support the manufacturing, procurement and distribution of 300M doses of the vaccine, with delivery initiating by the end of the year. The company also collaborated with SII to supply 1B doses for low/middle-income countries, with a commitment to provide 400M before the end […]Read More

Insights+

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Tuba Khan May 29, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019 PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (April 27 -May 01, 2020)

Tuba Khan May 4, 2020

WuXi Biologics and Aravive Collaborate to Develop Novel High-Affinity Bispecific Antibodies for Cancer and Fibrosis Published: Apr 30, 2020 | Tags: WuXi Biologics, Aravive, Collaborate, Develop, Novel, High-Affinity Bispecific Antibodies, Cancer, Fibrosis Novartis’ Enerzair Breezhaler (QVM149, IND/GLY/MF) Receives CHMP’s Recommendation for Approval as a Treatment for Uncontrolled Asthma Published: May 01, 2020 | Tags: Novartis, Enerzair, […]Read More

Insights+

Insights+: COVID-19 Healthcare News Monthly Updates

Vartika Singh May 1, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019 PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

COVID-19 Pharma

CEPI Collaborates with Clover to Support the Development of Vaccine

Tuba Khan April 28, 2020

Shots: CEPI to invest $3.5M in Clover to support the initiation of P-I clinical study of its protein-based COVID-19 S-Trimer vaccine in Australia. The vaccine is based on Clover’s Trimer-Tag vaccine technology platform, used to produce the spike proteins of the COVID-19 virus in a native trimeric form for use in a vaccine The collaboration […]Read More

Insights+

Insights+: COVID-19 Healthcare News Updates

Tuba Khan March 31, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (March 16-20, 2020)

Tuba Khan March 23, 2020

1. Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform Published: Mar 19, 2020 | Tags: Merck, Collaborates, Dragonfly, Develop, Commercialize, Novel Therapies, Utilizing, TriNKET Platform 2. BGI Reports the Availability of RT-PCR SARS-CoV-2 Test for Clinical Use in the US Published: Mar 20, 2020 | Tags: BGI, Reports, Availability, RT-PCR, SARS-CoV-2 […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens

MTPA and Aquestive Sign a License and Supply Agreement for Exservan (riluzole) to Treat ALS in the US

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Pfizer and BioNTech Signs an Agreement with Covax for Advance Purchase of Vaccine to Help Combat COVID-19

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

Incyte Reports Acceptance and Priority Review of BLA for Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

Pfizer and BioNTech Signs an Agreement with Covax for Advance Purchase of Vaccine to Help Combat COVID-19

Eli Lilly Reports Results of Bamlanivimab (LY-CoV555) in P-III BLAZE-2 Study for Preventing COVID-19 at Nursing Homes

Merck KGaA and GSK’s Bintrafusp Alfa Fails to Meet its Co-Primary Endpoints in Lung Cancer Study

Tags : CEPI

PharmaShots Weekly Snapshot (Nov 02-06, 2020)

CEPI to Invest ~$328M in Clover’s COVID-19 Vaccine Candidate

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

AstraZeneca Signs an Agreement with Serum Institute to Supply 1B

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

PharmaShots Weekly Snapshot (April 27 -May 01, 2020)

Insights+: COVID-19 Healthcare News Monthly Updates

CEPI Collaborates with Clover to Support the Development of Vaccine

Insights+: COVID-19 Healthcare News Updates

PharmaShots Weekly Snapshot (March 16-20, 2020)

Latest Posts

Insights+: Key Deals of JP Morgan Healthcare Conference 2021

Ervaxx and Cardiff University Collaborate to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens

Incyte Reports Acceptance and Priority Review of BLA for Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

Pfizer and BioNTech Signs an Agreement with Covax for Advance Purchase of Vaccine to Help Combat COVID-19

Tags : CEPI

Latest Posts

Categories

Related Topics